-

European Market for Nuclear Reactor Decommissioning - Growth, Trends, and Forecasts 2020-2025 - Research Reactors to Dominate the Market - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Europe Nuclear Reactor Decommissioning Market - Growth, Trends, and Forecasts (2020 - 2025)" report has been added to ResearchAndMarkets.com's offering.

The Europe nuclear reactor decommissioning market is expected to grow approximately at a CAGR of more than 10% during the forecast period 2020-2025. Factors such as the increasing number of nuclear reactors reaching operational retirement, declining prices of renewable power generation sources (i.e., wind & solar), which in turn are rendering nuclear power less economical, and growing sensitivity toward environmental issues are expected to drive the market in the coming years. However, the increasing adoption of alternate energy sources, such as gas-based power and solar power is likely to hinder the market growth during the forecast period.

  • The decommissioning activity of research reactors is expected to be the largest market during the forecast period, owing to the reduced requirement of the same, as there is a decreasing trend in research & development activity in the nuclear industry.
  • At least two reactor sites are expected to be suspended in Germany by 2020, similarly, during 2020-2025, around 4 reactor sites are likely to be shut down in the United Kingdom, and six in Germany. Therefore, these countries are expected to create enormous opportunities for nuclear-decommissioning market players.
  • France, Germany, Sweden, and Russia are the regional hotspots for the nuclear power reactor decommissioning market.

The Europe nuclear reactor decommissioning market is moderately consolidated. Some of the key players are Cavendish Nuclear Ltd., Fluor Corporation, GE Hitachi Nuclear Services, James Fisher and Sons PLC, and Electricite de France SA.

Key Topics Covered:

1 INTRODUCTION

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET OVERVIEW

4.1 Introduction

4.2 Market Size and Demand Forecast in USD billion, until 2025

4.3 Recent Trends and Developments

4.4 Government Policies and Regulations

4.5 Market Dynamics

4.5.1 Drivers

4.5.2 Restraints

4.6 Supply Chain Analysis

4.7 Porter's Five Forces Analysis

5 MARKET SEGMENTATION

5.1 Reactor Type

5.2 Application

5.4 Geography

6 COMPETITIVE LANDSCAPE

6.1 Mergers and Acquisitions, Joint Ventures, Collaborations, and Agreements

6.2 Strategies Adopted by Leading Players

6.3 Company Profiles

6.3.1 Babcock International Group PLC

6.3.2 Cavendish Nuclear Ltd

6.3.3 Electricite de France SA

6.3.4 Fluor Corporation

6.3.5 GE Hitachi Nuclear Services

6.3.6 James Fisher & Sons PLC

6.3.7 NorthStar Group Services, Inc.

6.3.8 Studsvik AB

6.3.9 WS Atkins Plc

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

For more information about this report visit https://www.researchandmarkets.com/r/g7n3xu

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Industry:

Research and Markets


Release Versions

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

Lonza Group, Catalent, and Recipharm Lead the $12.5 Billion Inhaled Drugs Contract Manufacturing Market, 2025-2033: Insights by Service, Product, End-Use and Region - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Inhaled Drugs Contract Manufacturing Market Forecast to 2033" has been added to ResearchAndMarkets.com's offering. The global inhaled drugs contract manufacturing market is experiencing significant growth, with its size projected to increase from USD 5.47 billion in 2024 to USD 12.56 billion by 2033. The market is set to grow at a compound annual growth rate (CAGR) of 9.82% from 2025 to 2033. This expansion is primarily driven by an increasing prevalence of respira...

U.S. Dental Prosthetics Market Intelligence Report 2025-2033 Featuring Dentsply Sirona, 3D Systems, Solventum, Ivoclar Vivadent, Institut Straumann and More - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "U.S. Dental Prosthetics Market Forecast to 2033" has been added to ResearchAndMarkets.com's offering. The U.S. dental prosthetics market, valued at USD 4.19 billion in 2024, is projected to surge to USD 9.74 billion by 2033, boasting a robust CAGR of 9.94% from 2025 to 2033. This impressive growth trajectory is spurred by the increasing demand for oral procedures, including implantation and cosmetic dentistry. Furthermore, significant technological advancements wit...

U.S. Dental Tourism Market Forecast to 2033 by Type of Service, Provider, Region and Country, Featuring Profiles of 10 Industry Players Including Sani Dental Group, BIDC, Dental Centre Turkey - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "U.S. Dental Tourism Market Forecast to 2033" report has been added to ResearchAndMarkets.com's offering. The U.S. dental tourism market size was estimated at USD 634.19 million in 2024 and is expected to reach USD 3.16 billion by 2033, growing at a CAGR of 19.76% from 2025 to 2033. Cost savings drive this growth, as dental procedures abroad are cheaper than in the U.S., even when including travel and lodging expenses. Limited dental insurance coverage for certain p...
Back to Newsroom